Apr 1 |
HCW Biologics GAAP EPS of -$0.15, revenue of $1.3M
|
Apr 1 |
HCW Biologics Reports Fourth Quarter 2023 and Fiscal Year End Financial Results And Business Highlights
|
Jan 25 |
Several Insiders Invested In HCW Biologics Flagging Positive News
|
Nov 14 |
HCW Biologics GAAP EPS of -$0.14, revenue of $174.77M
|
Nov 14 |
HCW Biologics Reports Third Quarter 2023 Financial Results And Recent Business Highlights
|
Nov 8 |
Investigator Sponsor of HCW Biologics’ Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual Meeting
|